Efficacy and Safety of a New Sperm Capacitation Method
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18-60
SponsorFecundis Lab SL
About this trial
Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to evaluate the efficacy and safety of HyperSperm, a new sperm capacitation method, in 300 semen samples with various characteristics and abnormalities, in an in vitro study over 12 months.
Eligibility criteria
Qualifiers
Ability to provide a semen sample via masturbation
Disqualifiers
Current diagnosis of a sexually transmitted infection (STI)
Previous diagnosis of hepatitis A, B, C, D, or HIV
Prior participation in this study
Participation in a clinical trial involving an intervention within the last 3 months
Trial design
Treatments tested in this trial
- Standard sperm preparation
- HyperSperm
Treatment groups
300 Participants
are divided into 5 treatment groupsLocations
4CIRH08017, BarcelonaBarcelona, Spain
Eugin Barcelona08006, BarcelonaBarcelona, Spain
Fertty08010, BarcelonaBarcelona, Spain
Natuvitro08029, BarcelonaBarcelona, Spain
Sponsors and collaborators
Fecundis Lab SL
Lead sponsor
Source ClinicalTrials.gov